Microba Life Sciences Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Microba Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $0.13. The average 1-year stock price forecast is 106.35% higher than the current stock price, while the lowest is $0.12 (+90.48%) and the highest is $0.15 (+138.10%).

Price Target: $0.13 (+106.35%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$0.12	$0.13	$0.13	$0.15
Change	+90.48%	+106.35%	+106.35%	+138.10%

Analyst Ratings

The average analyst rating for Microba Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Dec '25	Jan '26	Feb '26	Apr '26	May '26
Strong Buy	3	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Iain Wilkie Morgans	Morgans	Buy Maintains $0.29 → $0.15	Buy	Maintains	$0.29 → $0.15	+138.10%	May 14, 2026
Thomas Wakim Bell Potter	Bell Potter	Buy Maintains $0.12	Buy	Maintains	$0.12	+90.48%	May 1, 2026

Financial Forecast

Revenue This Year

16.12M

from 15.67M

2.90%

from 15.67M

Revenue Next Year

23.70M

from 16.12M

47.02%

from 16.12M

EPS This Year

-0.03

from -0.04

EPS Next Year

-0.02

from -0.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	3.73M	4.69M	5.42M	12.09M	15.67M	16.12M
Revenue Growth	28.31%	25.62%	15.60%	123.06%	29.60%	2.90%
Gross Profit	2.04M	2.37M	2.68M	5.91M	7.44M	8.30M
Gross Margin	54.61%	50.46%	49.41%	48.85%	47.49%	51.50%
Operating Income	-9.52M	-16.27M	-20.23M	-25.84M	-24.61M	-15.38M
Net Income	-7.52M	-11.47M	-12.68M	-19.94M	-14.94M	-17.10M
EPS	-	-	-	-	-0.04	-0.03
Free Cash Flow	-6.21M	-10.46M	-15.40M	-14.65M	-11.83M	-17.70M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue	2026	2027	2028
High	16.2M
Avg	16.1M
Low	16.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	3.4%
Avg	2.9%
Low	2.4%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.03
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-